Navigation Links
Safety Glasses Dispensers from Terra Universal, Inc.

ProductsSafety Glasses Dispensers from Terra Universal, Inc.
Company Terra Universal, Inc.
Item Safety Glasses Dispensers
Price 
Description These handy dispensers save space and organize gloves, safety glasses, wipers, hats, and other garb. They are the perfect benchtop storage bins for small parts used in labs, processing and manufacturing. Clear acrylic. Open-slot design for easy cleaning. Many other sizes and custom configurations available.
Info Terra Universal, Inc.Terra Universal, Inc.
800 S. Raymond Ave.
Fullerton, CA 92831

Call Terra Universal, Inc. to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-714-888-5389
Customer Service: 714-526-0100
Fax Number: 714-992-2179
Web Site: http://www.terrauniversal.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Safety Glasses Dispensers from Terra Universal, Inc.
2. Safety Glasses Dispensers from Terra Universal, Inc.
3. Cover Glasses from Santa Cruz Biotechnology, Inc.
4. Horizontal Laminar Flow Work Station from Terra Universal, Inc.
5. Benchtop Laminar Hood (Universal Hood) from Terra Universal, Inc.
6. Benchtop Laminar Flow Hood (Environmental Control Module) from Terra Universal, Inc.
7. Vertical Laminar Flow Work Station from Terra Universal, Inc.
8. Down Draft Work Station from Terra Universal, Inc.
9. Heated Processing Chamber from Terra Universal, Inc.
10. Pharmaceutical Compounding Chamber from Terra Universal, Inc.
11. Benchtop Ductless Exhaust Hood (Universal Hood) from Terra Universal, Inc.
1/4" to 1/8" Adapter for Reflectance Probe Holder from Ocean Optics
SHEEP SERUM (WITH 0.09% AZIDE) from AbD Serotec
...acity to self renew and their ability to different...hich can commit to further maturation along specif...of differentiating into multiple cell types includ...ng the isolation and expansion of NSCs, the status...
Mouse Anti-Macrophage L1 protein Calprotectin Monoclonal Antibody, Unconjugated, Clone B314.1 (MAC 387) from Abcam
Biology Products:
(Date:11/22/2009)...team of pioneering South Korean scientists have su...y plastics through bioengineering, rather than thr...groundbreaking research, which may now allow for t...s, is published in two papers in the journal Biot...s 50th anniversary. , Polymers are molecules fo...
(Date:11/22/2009)...Cambridge, MA November 23, 2009 Agios Pharmaceut...ablished, for the first time, that the mutated IDH... a cancer-causing gene, or oncogene. This breakthr... produces a metabolite, 2-hydroxyglutarate (2HG), ...t progression of gliomas, the most common type of ...
(Date:11/20/2009)... a research report published in the November 2009 ...ics.org ), scientists show how a family of genes (... genes) are responsible for production of ethylene...nt, and this information lays the foundation for f...disease resistant, able to survive and thrive in d...
Breaking Biology News(10 mins):Bioengineers succeed in producing plastic without the use of fossil fuels 2Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 2Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 3Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 4It's a gas: New discovery may lead to heartier, high-yielding plants 2Hologic to Release Fourth Quarter and Fiscal 2009 Operating Results on Monday November 9 2009 58885 1Hologic to Release Fourth Quarter and Fiscal 2009 Operating Results on Monday November 9 2009 58885 2Hanger Orthopedic Group Inc Announces Third Quarter 2009 Earnings Release Conference Call 58881 1Hanger Orthopedic Group Inc Announces Third Quarter 2009 Earnings Release Conference Call 58881 2ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema 28MIVI II DME 29 14355 1ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema 28MIVI II DME 29 14355 2ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema 28MIVI II DME 29 14355 3ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema 28MIVI II DME 29 14355 4
...s announces the latest addition to its Cumulative ... (Cumitechs) publication series: Cumitech 46 -- L... Parasitic Diseases. , This Cumitech is intended ...d other members of the patient care team in the ap...ests for the diagnosis and management of blood-bor...
...ch team has developed the first small molecule tha...n balancing sodium levels, paving the way for drug...nditions. , The human epithelial sodium channel ...ch as the lungs, kidneys, and colon, and it is vit...essure. Interestingly, while there are available d...
...born in India and Sri Lanka are three times more l...n pregnancy (hyperemesis gravidarum) than ethnic N...nstitute of Public Healths study of 900, 000 first...Registry of Norway over a forty year period. , E...t women experience some degree of nausea and vomit...
Other Biology News:Extreme nausea and vomiting varies among pregnant women from different countries 2
(Date:11/20/2009)...0 Cell Therapeutics, Inc...t the Ninth Circuit Court of Appeals reversed a U....be allowed to pursue all of its claims against The... Court for trial. CTI filed a complaint against T...ent consultant for CTI,s product TRISENOX, in 2007...
(Date:11/19/2009)... Danish Prince Joachim inaugurated ...nt in Kalundborg, Denmark, on Wednesday, November ...argest 2nd generation ethanol demonstration bioref...n the plant,s innovative process for converting st...the first to market with commercial enzymes for co...
(Date:11/19/2009)...PRNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex:...owing letter to its shareholders, discussing the C...a Biopharmaceuticals Holdings, Inc. (CHBP), an int...ople,s Republic of China. The merger gives NeoStem...eutical Co. Ltd., CHBP,s primary operating subsidi...
(Date:11/19/2009)...PRNewswire/ - Aegera Therapeutics Inc. announced t...ed Phase 2B study of AEG35156, a targeted antisens...e oncology indications. ,, The study, entitled ...inked Inhibitor of Apoptosis (XIAP) Antisense AEG3...e and Idarubicin in AML Following Failure of a Sin...
Breaking Biology Technology:Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2